.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Mac Pharms is stocked at 298 licensed dispensaries across Michigan, New York, and Arizona, 193 of them in Michigan, with the deepest coverage in New Buffalo, Detroit, Monroe, Inkster, and Ann Arbor. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Mac Pharms concentrated its July 2026 mix in Vapor Pens at 37.63% share with 40.33% year-over-year growth and 64.98% month-over-month lift, while Flower held 16.97% share with 62.82% YoY growth but declined 12.77% MoM. Pre-Roll accounted for 21.61% share with a 2.79% YoY decline alongside a 12.48% MoM uptick, and Edible sat at 15.48% share with a 31.20% YoY drop and 6.65% MoM gain. Concentrates remained smaller at 8.31% share with a 62.59% YoY decline but a 73.76% MoM rebound, indicating a tactical pivot toward inhalable formats even as total brand sales fell 4.01% YoY and average price rose 5.15%, a mix that implies margin-first choices are reshaping volume trajectories.
The surge in Vapor Pens alongside MoM recovery in Concentrates (+73.76%) and Pre-Roll (+12.48%) suggests Mac Pharms is prioritizing faster-cycling inhalables to compensate for Edible’s 31.20% YoY erosion and Flower’s 12.77% MoM pullback, which together shift the basket toward higher-ticket inhalation SKUs despite a brand-level 4.01% YoY sales decline. With Vapor Pens ranked 37 in Michigan and carrying 37.63% of the mix, the brand’s positioning hinges on defending pen share to anchor traffic while using MoM momentum in Concentrates to rebuild premium perception; the pattern implies pricing power (avg price +5.15% YoY) is being used selectively, but sustained growth will require converting the Flower YoY strength (+62.82%) into consistent MoM velocity and stabilizing Edible’s loss so the mix doesn’t over-index on one category.
Competitive Landscape
Mac Pharms sits at rank #37 in Michigan Vapor Pens for July 2026, improving 12 positions year over year from #49 and slipping 6 spots since April 2026 when it was #43, while still trailing its peak at #21 from September 2025; meanwhile, MKX Oil Company moved up from #3 to #1 as of July 2026 with a 42.9% year-over-year sales increase, and Mitten Extracts fell from #1 to #2 alongside an 18.8% sales decline, indicating Mac Pharms’ mid-tier recovery is occurring against a top tier that is concentrating share upward as leaders gain or defend positions faster than Mac Pharms is climbing.
Notable Products
Fuzzy Navel Gummies 4-Pack (200mg) posted the standout move in July 2026 with a 95.1% month-over-month jump to rank 3, while Lush Pineapple Gummies 5-Pack (200mg) fell 30.1% to rank 5 and Daytime - Berry Nana Gummies 4-Pack (200mg) dropped 46.8% at rank 8. Despite holding rank 1, Sour Jolly Apple Gummies 4-Pack (200mg) declined 25.0%, and Orange Burst Gummies 5-Pack (200mg) rose 12.8% to rank 2, indicating volatility within the top tier. Eight of the top ten are Edible SKUs, concentrating share in gummies even as Vapor Pens occupy ranks 7 and 9 with stable placement but no reported growth. The pattern implies Mac Pharms is pivoting toward depth in gummies where rapid mix shifts can reallocate volume quickly, while pens serve as steady but secondary anchors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
